Derek Glennie
Chief Tech/Sci/R&D Officer at Spartan Bioscience, Inc.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Roger Eacock | M | - |
Spartan Bioscience, Inc.
 Spartan Bioscience, Inc. Medical SpecialtiesHealth Technology Spartan Bioscience, Inc. provides on-demand deoxyribonucleic acid testing systems. Its automated systems are indicated as an aid for clinicians to determine therapeutic strategy for drugs metabolized by the CYP450 2C19 genetic pathway. The company was founded by Paul Lem, John Lem and Jamie Spiegelman in 2005 and is headquartered in Ottawa, Canada. | 4 years |
| Jamie Spiegelman | M | - |
Spartan Bioscience, Inc.
Spartan Bioscience, Inc. Medical SpecialtiesHealth Technology Spartan Bioscience, Inc. provides on-demand deoxyribonucleic acid testing systems. Its automated systems are indicated as an aid for clinicians to determine therapeutic strategy for drugs metabolized by the CYP450 2C19 genetic pathway. The company was founded by Paul Lem, John Lem and Jamie Spiegelman in 2005 and is headquartered in Ottawa, Canada. | 19 years |
| Seymour Liebman | M | 74 |
Spartan Bioscience, Inc.
Spartan Bioscience, Inc. Medical SpecialtiesHealth Technology Spartan Bioscience, Inc. provides on-demand deoxyribonucleic acid testing systems. Its automated systems are indicated as an aid for clinicians to determine therapeutic strategy for drugs metabolized by the CYP450 2C19 genetic pathway. The company was founded by Paul Lem, John Lem and Jamie Spiegelman in 2005 and is headquartered in Ottawa, Canada. | - |
| Rochelle Stenzler | F | 70 |
Spartan Bioscience, Inc.
Spartan Bioscience, Inc. Medical SpecialtiesHealth Technology Spartan Bioscience, Inc. provides on-demand deoxyribonucleic acid testing systems. Its automated systems are indicated as an aid for clinicians to determine therapeutic strategy for drugs metabolized by the CYP450 2C19 genetic pathway. The company was founded by Paul Lem, John Lem and Jamie Spiegelman in 2005 and is headquartered in Ottawa, Canada. | 4 years |
| Maryscott Greenwood | F | 58 |
Spartan Bioscience, Inc.
Spartan Bioscience, Inc. Medical SpecialtiesHealth Technology Spartan Bioscience, Inc. provides on-demand deoxyribonucleic acid testing systems. Its automated systems are indicated as an aid for clinicians to determine therapeutic strategy for drugs metabolized by the CYP450 2C19 genetic pathway. The company was founded by Paul Lem, John Lem and Jamie Spiegelman in 2005 and is headquartered in Ottawa, Canada. | 4 years |
| Sean Tomalty | M | - |
Spartan Bioscience, Inc.
Spartan Bioscience, Inc. Medical SpecialtiesHealth Technology Spartan Bioscience, Inc. provides on-demand deoxyribonucleic acid testing systems. Its automated systems are indicated as an aid for clinicians to determine therapeutic strategy for drugs metabolized by the CYP450 2C19 genetic pathway. The company was founded by Paul Lem, John Lem and Jamie Spiegelman in 2005 and is headquartered in Ottawa, Canada. | 9 years |
| Steve Edgett | M | - |
Spartan Bioscience, Inc.
Spartan Bioscience, Inc. Medical SpecialtiesHealth Technology Spartan Bioscience, Inc. provides on-demand deoxyribonucleic acid testing systems. Its automated systems are indicated as an aid for clinicians to determine therapeutic strategy for drugs metabolized by the CYP450 2C19 genetic pathway. The company was founded by Paul Lem, John Lem and Jamie Spiegelman in 2005 and is headquartered in Ottawa, Canada. | 5 years |
| Robert Bowcock | M | - |
Spartan Bioscience, Inc.
Spartan Bioscience, Inc. Medical SpecialtiesHealth Technology Spartan Bioscience, Inc. provides on-demand deoxyribonucleic acid testing systems. Its automated systems are indicated as an aid for clinicians to determine therapeutic strategy for drugs metabolized by the CYP450 2C19 genetic pathway. The company was founded by Paul Lem, John Lem and Jamie Spiegelman in 2005 and is headquartered in Ottawa, Canada. | - |
| Tim Keane | M | - |
Spartan Bioscience, Inc.
Spartan Bioscience, Inc. Medical SpecialtiesHealth Technology Spartan Bioscience, Inc. provides on-demand deoxyribonucleic acid testing systems. Its automated systems are indicated as an aid for clinicians to determine therapeutic strategy for drugs metabolized by the CYP450 2C19 genetic pathway. The company was founded by Paul Lem, John Lem and Jamie Spiegelman in 2005 and is headquartered in Ottawa, Canada. | - |
| William Rhoads | M | - |
Spartan Bioscience, Inc.
Spartan Bioscience, Inc. Medical SpecialtiesHealth Technology Spartan Bioscience, Inc. provides on-demand deoxyribonucleic acid testing systems. Its automated systems are indicated as an aid for clinicians to determine therapeutic strategy for drugs metabolized by the CYP450 2C19 genetic pathway. The company was founded by Paul Lem, John Lem and Jamie Spiegelman in 2005 and is headquartered in Ottawa, Canada. | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Arun Menawat | M | 69 |
Spartan Bioscience, Inc.
Spartan Bioscience, Inc. Medical SpecialtiesHealth Technology Spartan Bioscience, Inc. provides on-demand deoxyribonucleic acid testing systems. Its automated systems are indicated as an aid for clinicians to determine therapeutic strategy for drugs metabolized by the CYP450 2C19 genetic pathway. The company was founded by Paul Lem, John Lem and Jamie Spiegelman in 2005 and is headquartered in Ottawa, Canada. | 1 years |
| Paul G. Markell | M | - |
Spartan Bioscience, Inc.
Spartan Bioscience, Inc. Medical SpecialtiesHealth Technology Spartan Bioscience, Inc. provides on-demand deoxyribonucleic acid testing systems. Its automated systems are indicated as an aid for clinicians to determine therapeutic strategy for drugs metabolized by the CYP450 2C19 genetic pathway. The company was founded by Paul Lem, John Lem and Jamie Spiegelman in 2005 and is headquartered in Ottawa, Canada. | 13 years |
| Chris Harder | M | - |
Spartan Bioscience, Inc.
Spartan Bioscience, Inc. Medical SpecialtiesHealth Technology Spartan Bioscience, Inc. provides on-demand deoxyribonucleic acid testing systems. Its automated systems are indicated as an aid for clinicians to determine therapeutic strategy for drugs metabolized by the CYP450 2C19 genetic pathway. The company was founded by Paul Lem, John Lem and Jamie Spiegelman in 2005 and is headquartered in Ottawa, Canada. | 12 years |
| Katy Pelletier | F | - |
Spartan Bioscience, Inc.
Spartan Bioscience, Inc. Medical SpecialtiesHealth Technology Spartan Bioscience, Inc. provides on-demand deoxyribonucleic acid testing systems. Its automated systems are indicated as an aid for clinicians to determine therapeutic strategy for drugs metabolized by the CYP450 2C19 genetic pathway. The company was founded by Paul Lem, John Lem and Jamie Spiegelman in 2005 and is headquartered in Ottawa, Canada. | 9 years |
| Charudutt Shah | M | - |
Spartan Bioscience, Inc.
Spartan Bioscience, Inc. Medical SpecialtiesHealth Technology Spartan Bioscience, Inc. provides on-demand deoxyribonucleic acid testing systems. Its automated systems are indicated as an aid for clinicians to determine therapeutic strategy for drugs metabolized by the CYP450 2C19 genetic pathway. The company was founded by Paul Lem, John Lem and Jamie Spiegelman in 2005 and is headquartered in Ottawa, Canada. | - |
Statistics
| Country | Connections | % of total |
|---|---|---|
| Canada | 15 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Derek Glennie
- Personal Network
